Mirae Asset Global Investments
SAGE

Mirae Asset Global Investments’s Sage Therapeutics SAGE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$22.1K Buy
2,419
+362
+18% +$3.3K ﹤0.01% 1387
2025
Q1
$17K Buy
2,057
+18
+0.9% +$149 ﹤0.01% 1401
2024
Q4
$11.3K Sell
2,039
-169
-8% -$936 ﹤0.01% 1497
2024
Q3
$16.1K Buy
2,208
+411
+23% +$3K ﹤0.01% 1462
2024
Q2
$19.2K Sell
1,797
-36,771
-95% -$393K ﹤0.01% 1382
2024
Q1
$1.3M Buy
38,568
+1,693
+5% +$56.9K ﹤0.01% 1400
2023
Q4
$799K Sell
36,875
-2,708
-7% -$58.7K ﹤0.01% 1734
2023
Q3
$815K Buy
39,583
+8,561
+28% +$176K ﹤0.01% 1630
2023
Q2
$1.46M Sell
31,022
-1,659
-5% -$78K ﹤0.01% 1370
2023
Q1
$1.37M Buy
32,681
+6,247
+24% +$262K ﹤0.01% 1382
2022
Q4
$1.01M Buy
26,434
+23
+0.1% +$877 ﹤0.01% 1491
2022
Q3
$1.03M Buy
26,411
+10,003
+61% +$392K ﹤0.01% 1461
2022
Q2
$530K Buy
+16,408
New +$530K ﹤0.01% 1719
2021
Q2
Sell
-3,998
Closed -$300K 1732
2021
Q1
$300K Sell
3,998
-816
-17% -$61.2K ﹤0.01% 1416
2020
Q4
$417K Buy
4,814
+380
+9% +$32.9K ﹤0.01% 1366
2020
Q3
$271K Buy
+4,434
New +$271K ﹤0.01% 1356
2020
Q2
Sell
-10,126
Closed -$291K 1513
2020
Q1
$291K Sell
10,126
-2,953
-23% -$84.9K ﹤0.01% 1207
2019
Q4
$945K Buy
13,079
+2,475
+23% +$179K 0.01% 981
2019
Q3
$1.49M Buy
10,604
+493
+5% +$69.2K 0.01% 791
2019
Q2
$1.85M Buy
10,111
+527
+5% +$96.5K 0.01% 722
2019
Q1
$1.53M Buy
9,584
+908
+10% +$144K 0.01% 705
2018
Q4
$831K Buy
8,676
+239
+3% +$22.9K 0.01% 819
2018
Q3
$1.19M Buy
8,437
+1,391
+20% +$197K 0.01% 783
2018
Q2
$1.1M Sell
7,046
-22
-0.3% -$3.44K 0.02% 493
2018
Q1
$1.14M Buy
7,068
+1,118
+19% +$180K 0.01% 469
2017
Q4
$980K Buy
5,950
+1,638
+38% +$270K 0.01% 480
2017
Q3
$269K Sell
4,312
-18,000
-81% -$1.12M ﹤0.01% 606
2017
Q2
$1.78M Hold
22,312
0.03% 329
2017
Q1
$1.59M Buy
22,312
+3,654
+20% +$260K 0.03% 313
2016
Q4
$953K Sell
18,658
-2,153
-10% -$110K 0.02% 334
2016
Q3
$959K Buy
+20,811
New +$959K 0.02% 352